View Federal Register notices of proposed exclusive licenses. Clicking on the "View" links will display the Federal Register Notice in a new tab. You can also search directly on the Federal Register site.
Interested parties should notify this office in writing of their interest in filing a formal proposal no later than July 9, 1999. Potential CRADA Collaborators will then have an additional thirty (30) days to submit a formal proposal.
Interested parties should notify this office in writing of their interest in filing a formal proposal no later than June 18, 1999. They will then have an additional thirty (30) days to submit a formal proposal.
Interested parties should notify the National Cancer Institute's Technology Development & Commercialization Branch, in writing, of their intent to file a formal proposal no later than May 24, 1999. Formal proposals must be submitted to this office no later than June 7, 1999.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before July 7, 1999 will be considered.
Inquiries regarding CRADA proposals and scientific matters may be forwarded at any time. Confidential CRADA proposals, preferably two pages or less, must be submitted to the NCI on or before May 3, 1999. Guidelines for preparing full CRADA proposals will be communicated shortly thereafter to all respondents who have been selected.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before May 24, 1999 will be considered.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before March 29, 1999 will be considered.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before March 23, 1999 will be considered.
Respondees interested in licensing the invention(s) will be required to submit an ``Application for License to Public Health Service Inventions'' on or before March 1, 1999.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before January 12, 1999, will be considered.
Respondees interested in licensing the invention(s) will be required to submit an ``Application for License to Public Health Service Inventions'' on or before January 8, 1999 for priority consideration.
Confidential CRADA statements of interest describing the proposed research, preferably one page or less, must be submitted to NCI on or before December 29, 1998. Guidelines for preparing full CRADA proposals will be communicated shortly thereafter to all respondents who have been selected on the basis of mutual scientific interest.
